Cargando…
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options
Preclinical forms of gastrointestinal stromal tumor (GIST), small asymptomatic lesions, called microGIST, are detected in approximately 30% of the general population. Gastrointestinal stromal tumor driver mutation can be already detected in microGISTs, even if they do not progress into malignant can...
Autores principales: | Ravegnini, Gloria, Fosso, Bruno, Ricci, Riccardo, Gorini, Francesca, Turroni, Silvia, Serrano, Cesar, Pilco‐Janeta, Daniel F., Zhang, Qianqian, Zanotti, Federica, De Robertis, Mariangela, Nannini, Margherita, Pantaleo, Maria Abbondanza, Hrelia, Patrizia, Angelini, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357631/ https://www.ncbi.nlm.nih.gov/pubmed/35633186 http://dx.doi.org/10.1111/cas.15441 |
Ejemplares similares
-
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs
por: Ravegnini, Gloria, et al.
Publicado: (2022) -
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors
por: Ravegnini, Gloria, et al.
Publicado: (2019) -
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis
por: Ravegnini, Gloria, et al.
Publicado: (2015) -
Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis—Deepening Heterogeneity for a Personalized Therapy
por: Ravegnini, Gloria, et al.
Publicado: (2020) -
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility
por: Ravegnini, Gloria, et al.
Publicado: (2019)